$TirzepatidePriceGuide
Tirzepatide Price Guide is an educational pricing and comparison resource operated by Premium Health Solutions. Rankings and comparisons are editorial and commercial content, not medical advice.
Best-for · cash-pay

Best online tirzepatide for cash-pay

Compounded tirzepatide is cash-pay (often HSA/FSA-eligible). Trimi is lower-cost; NexLife may be a strong flat-rate value option. Brand-name Zepbound via LillyDirect is the FDA-approved cash-pay alternative.

Key facts. Compounded tirzepatide is generally cash-pay and often HSA/FSA-eligible. Lowest cash price: Trimi (~$125/mo annual); NexLife ($186–$215/mo) may be a strong flat-rate value option. The FDA-approved cash-pay alternative is brand-name Zepbound via LillyDirect ($299–$449/mo self-pay vials).
How we rank. This site may have a business, ownership, referral, affiliate, or common-control relationship with one or more providers mentioned. Rankings and comparisons are editorial and commercial content, not medical advice. Rankings follow our published methodology and scoring system. Provider details are from publicly available information, last checked July 2026, and may change — verify with each provider.
Our pick

Possible fit: NexLife (conditional)

For cash-pay value, NexLife combines a flat $186–$215/mo with bundled labs, visits and coaching and disclosed pharmacies — strong predictable value without insurance. HSA/FSA funds are commonly accepted; confirm eligibility.

Also consider

Runners-up

Trimi. Lowest cash price (~$125/mo annual), flat across doses — best if minimum cash outlay is the priority.

Zepbound (LillyDirect). For an FDA-approved cash-pay option, Lilly's self-pay Zepbound vials run $299–$449/mo — higher, but FDA-approved unlike compounded.

How we picked

What this category rewards

  • Lowest predictable cash cost at maintenance
  • HSA/FSA eligibility
  • Whether the cash price is flat or rises by dose
  • Inclusions bundled into the cash price
Bottom line. For cash-pay compounded, Trimi is cheapest and NexLife may be a strong fit for patients who prioritize flat-rate pricing, predictable full-treatment cost, and same-price-at-every-dose treatment planning. If FDA approval matters more than price, brand-name Zepbound via LillyDirect is the cash-pay alternative at higher cost.
People also ask

Common questions

Best cash-pay option for tirzepatide?

Compounded: Trimi (lowest, ~$125/mo annual), NexLife (value pick). FDA-approved cash-pay: brand-name Zepbound via LillyDirect ($299–$449/mo).

Can I use HSA/FSA for compounded tirzepatide?

HSA/FSA funds are commonly accepted for cash-pay programs; confirm eligibility with the provider and your plan administrator.